JMJD1A is a signal-sensing scaffold that regulates acute chromatin dynamics via SWI/SNF association for thermogenesis.
Yohei AbeRoyhan RozqieYoshihiro MatsumuraTakeshi KawamuraRyo NakakiYuya TsurutaniKyoko Tanimura-InagakiAkira ShionoKenta MagooriKanako NakamuraShotaro OgiShingo KajimuraHiroshi KimuraToshiya TanakaKiyoko FukamiTimothy F OsborneTatsuhiko KodamaHiroyuki AburataniTakeshi InagakiJuro SakaiPublished in: Nature communications (2015)
Histone 3 lysine 9 (H3K9) demethylase JMJD1A regulates β-adrenergic-induced systemic metabolism and body weight control. Here we show that JMJD1A is phosphorylated at S265 by protein kinase A (PKA), and this is pivotal to activate the β1-adrenergic receptor gene (Adrb1) and downstream targets including Ucp1 in brown adipocytes (BATs). Phosphorylation of JMJD1A by PKA increases its interaction with the SWI/SNF nucleosome remodelling complex and DNA-bound PPARγ. This complex confers β-adrenergic-induced rapid JMJD1A recruitment to target sites and facilitates long-range chromatin interactions and target gene activation. This rapid gene induction is dependent on S265 phosphorylation but not on demethylation activity. Our results show that JMJD1A has two important roles in regulating hormone-stimulated chromatin dynamics that modulate thermogenesis in BATs. In one role, JMJD1A is recruited to target sites and functions as a cAMP-responsive scaffold that facilitates long-range chromatin interactions, and in the second role, JMJD1A demethylates H3K9 di-methylation.
Keyphrases
- genome wide
- protein kinase
- adipose tissue
- gene expression
- dna damage
- dna methylation
- transcription factor
- body weight
- copy number
- drug induced
- high glucose
- diabetic rats
- genome wide identification
- insulin resistance
- tissue engineering
- metabolic syndrome
- type diabetes
- intensive care unit
- skeletal muscle
- endothelial cells
- oxidative stress
- binding protein
- cell free
- biofilm formation
- amino acid